Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 337 K345 K353 K374 K381 K403 K 1.51 M Research & development —————— — Operating income 2.89 M6.53 M3.23 M3.26 M3.41 M3.56 M 13.46 M Non-Operating Income, Total 1 M1.02 M1.11 M1.06 M1.04 M1.03 M 4.23 M Interest expense, net of interest capitalized 2.27 M2.33 M2.35 M2.26 M2.1 M2.08 M 8.79 M Non-Operating Income, excl. Interest Expenses -1.27 M-1.31 M-1.24 M-1.2 M-1.06 M-1.05 M -4.56 M Unusual income/expense —————— — Pretax income 99 K3.04 M434 K617 K490 K485 K 2.03 M Equity in earnings —————— — Taxes 21 K-91 K91 K76 K103 K101 K 371 K Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 78 K3.13 M343 K541 K387 K384 K 1.66 M Discontinued operations —————— — Net income 78 K3.13 M343 K541 K387 K384 K 1.66 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 78 K3.13 M343 K541 K387 K384 K 1.66 M Basic earnings per share (Basic EPS) 0.020.610.070.10.080.08 0.33 Diluted earnings per share (Diluted EPS) 0.020.610.070.10.080.08 0.33 Average basic shares outstanding 5 1395 1455.14 M5.12 M4.91 M4.87 M — Diluted shares outstanding 5 1395 1455.14 M5.12 M4.91 M4.87 M — EBITDA 776 K4.39 M1.05 M1.19 M1.46 M1.66 M 5.36 M EBIT 603 K4.19 M872 K997 K1.29 M1.47 M 4.63 M Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 173 K197 K177 K197 K170 K183 K 727 K